A coalition of state attorneys general, including those in Pennsylvania and New Jersey, has reached agreements with two ...

About 18.7 million people will save $7.4 billion next year alone thanks to changes to Medicare drug benefits, the ...

When patents for name brand medicines expire, the price of that medicine drops significantly as generic versions enter the market, but that process can take a while.

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS ...

Sen. Baldwin says opponent Hovde “opposes efforts to negotiate with the big pharmaceutical companies to lower the price of ...

The Alzheimer's disease drug Kisunla will face major reimbursement challenges in the U.K. after the cost-effectiveness ...

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...

A panel of Maryland lawmakers has approved a plan to enable a state board to cap the cost that state and local governments ...

Expressing concern over the decision to hike prices of eight essential drugs by 50 per cent, the Congress on Saturday urged ...

Most U.S. states do not currently cover highly sought after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...